Mayoly reveals its new visual identity to reaffirm its values and ambition

Learn more


Our aim is to become a global leader in Gastroenterology and Dermocosmetics

MAYOLY is a family-owned, independent, French pharmaceutical and dermatological laboratory, generating a turnover of €519 million (12 months proforma net revenue), of which 65% is generated outside France, our home market. Through our subsidiaries, we have an international presence in 20 countries – China, Russia, Mexico, Ukraine, Kazakhstan, Belarus, Belgium, Italy, Germany, United Kingdom, Spain, Lithuania, Czech Republic, Romania, Poland, Slovakia, Algeria, Tunisia, Vietnam, Singapore – as well as distributors in over 100 countries.

Our portfolio is firmly focused on Gastroenterology, from specialist hospital products to the OTC market, and on Dermocosmetics, notably with the Topicrem® and BeauTerra® brands.

Our growth, beyond the geographic expansion and performance of our brands, is also underpinned by our ability to establish strong partnerships.

Our ambition to become a global leader in Gastroenterology and Dermocosmetics products is based on three strategic pillars: Developing our international brands, innovating through the launch of new products and boosting external growth through the acquisition of new technologies or complementary companies.

Our priorities for external growth

  • Projects in the final phase of development in Gastroenterology and Dermocosmetics.
  • Projects concerning products already on the market.
  • Companies or products in the field of Consumer Healthcare.
  • New commercial partnerships: Mainly in Europe, LATAM and APAC.


Contact our M&A, Business Development and Alliances team: